- Headquarters
- Seattle, United States · North America
- Value chain
- Research & IP(Research & design)
- What that means
- Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
- Founded
- 1998
- Ownership
- Listed
- Listing
- NYSE American:CATX on Google Finance
- Website
- perspectivetherapeutics.com
- Relevance
- Low at its strongest, in Nuclear Medicine & Radioisotope Technologies
In 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #40 of 50
Formerly IsoRay (Cs-131 brachytherapy seeds), it now develops lead-212 alpha radioligand therapies with in-house Pb-212 generator technology.
Relevance: Lead-212 therapy developer, early stage